Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Suehisa

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Angiology : a Journal of the International Union of Angiology|March 1, 1995
Involvement of dysplasminogenemia in occurrence of deep vein thrombosisT Kawasaki, J Kambayashi, Y Uemura, et al.
British Journal of Haematology|September 13, 2001
Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosusJ Nojima, H Kuratsune, E Suehisa, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 1, 1992
[Negative interference with peroxidase-coupled enzymatic serum creatinine assay by a hemostatic drug containing a hydroquinone structure]R Fushimi, A Suminoe, E Suehisa, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 1, 1990
[Development of ELISPOT assay for thyroid autoantibody-producing cells]T Kaneda, Y Iwatani, N Amino, et al.
Rheumatology (Oxford, England)|April 1, 2008
Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosusJ Nojima, Y Masuda, Y Iwatani, et al.
Thrombosis Research|July 3, 1998
Three novel missense mutations in unrelated Japanese patients with type I and type II protein S deficiency and venous thrombosisH Fujimura, J Kambayashi, H Kato, et al.
Surgery Today|January 1, 1993
Portal vein calcification: a clinical review of the last 50 years and report of a case associated with dysplasminogenemiaT Kawasaki, J Kambayashi, M Sakon, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1991
[Examination of the inhibitor to factor VIII in non-haemophilic patient]M Suetomo, E Suehisa, K Nishimura, et al.
Clinical Chemistry|September 1, 1988
Protein C in human plasma determined by homogeneous enzyme immunoassay with use of a centrifugal analyzerM Shimamoto, T Yoshimura, N Kimura, et al.
British Journal of Haematology|March 1, 1997
Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulantJ Nojima, E Suehisa, N Akita, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Angiology : a Journal of the International Union of Angiology|March 1, 1995
Involvement of dysplasminogenemia in occurrence of deep vein thrombosisT Kawasaki, J Kambayashi, Y Uemura, et al.
British Journal of Haematology|September 13, 2001
Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosusJ Nojima, H Kuratsune, E Suehisa, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 1, 1992
[Negative interference with peroxidase-coupled enzymatic serum creatinine assay by a hemostatic drug containing a hydroquinone structure]R Fushimi, A Suminoe, E Suehisa, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 1, 1990
[Development of ELISPOT assay for thyroid autoantibody-producing cells]T Kaneda, Y Iwatani, N Amino, et al.
Rheumatology (Oxford, England)|April 1, 2008
Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosusJ Nojima, Y Masuda, Y Iwatani, et al.
Thrombosis Research|July 3, 1998
Three novel missense mutations in unrelated Japanese patients with type I and type II protein S deficiency and venous thrombosisH Fujimura, J Kambayashi, H Kato, et al.
Surgery Today|January 1, 1993
Portal vein calcification: a clinical review of the last 50 years and report of a case associated with dysplasminogenemiaT Kawasaki, J Kambayashi, M Sakon, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1991
[Examination of the inhibitor to factor VIII in non-haemophilic patient]M Suetomo, E Suehisa, K Nishimura, et al.
Clinical Chemistry|September 1, 1988
Protein C in human plasma determined by homogeneous enzyme immunoassay with use of a centrifugal analyzerM Shimamoto, T Yoshimura, N Kimura, et al.
British Journal of Haematology|March 1, 1997
Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulantJ Nojima, E Suehisa, N Akita, et al.
Pageof 3